TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE-CHALLENGE OF DOUBLE ANTI-HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES
Anno:
2023
INTRODUCTION Cardiovascular diseases (CVD) and Cancer (C), the most important causes of mortality worldwide. share many risk factors and common pathophysiological processes such as chronic inflammation and unfavorable cardio-metabolic profile. Progress in oncological treatments improved the survival of oncological patients (Pt) but have increased the likelihood of short- and…